Structure, Relationship, Ideology, or, How Would We Know a "New Public Law" If We Saw It?

What Do We Know, How Do We Know It, and How Can We Best Apply It?

Adequate Nutrition May get You Home: Effect of Caloric/Protein Deficits on the Discharge Destination of Critically Ill Surgical Patients 37 D. Dante Yeh, MD; Eva Fuentes, MD; Sadeq A. Quraishi, MD, MHA, MMScH; Catrina Cropano, MSc; Haytham Kaafarani, MD, MPH; Jarone Lee, MD, MPH; David R. King, MD; Marc DeMoya, MD; Peter Fagenholz, MD; Kathryn Butler, MD; Yuchiao Chang, PhD; and George Velmahos...

Treatment of chronic hyponatremia: now we know how, but do we know when or if?

How do we know that we know what we know?

How Science Works’ is now the focus of the national science specifications in English schools. This article is a brief introduction to the philosophy of science from the Greeks to the present day that underpins this notion. From September 2006, the emphasis for teaching science at GCSE is on ‘How Science Works’. This focus will also shape the revisions of the AS and A2 specifications from Septe...

It’s the End of Ideology as We Know It

Scholars have long focused on socio-psychological attachment, elite discourse and rational action to explain the nature and structure of ideologies. Recently genetic and neurobiological influences have also emerged as predictors of ideological preferences. So far however, there has been little synthesis of these findings into the larger discourse on the structures and manifestations of ideology...

Can a marker be a surrogate for development of cancer, and would we know it if it exists?

Carcinogenesis proceeds through a very long preclinical period. Our collective hope is that multiple opportunities exist for chemoprevention to arrest or reverse progression towards malignancy. In the hope of faster progress with fewer subjects and lower total cost, much effort is being expended on the search for reliable biomarkers to predict the likelihood of developing cancer and/or to signa...